中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:(Binghe CHEN)

1.Analysis of Siewert classification, microsatellite instability and HER2 expression in 242 cases of adenocarcinoma of esophagogastric junction

Xinjun WU ; Qingzu GAO ; Yan LI ; Shuaichao LI ; Qiao ZHANG ; Binghe CHEN

International Journal of Surgery 2021;48(11):769-773,f4

2.Results of combined therapy for 1260 patients with small cell lung cancer.

Dongfu CHEN ; Xiangru ZHANG ; Weibo YIN ; Yan SUN ; Yanjun MIAO ; Fengyi FENG ; Jinwan WANG ; Mei WANG ; Hongxing ZHANG ; Qinfu FENG ; Binghe XU ; Yuankai SHI

Chinese Journal of Oncology 2002;24(6):602-604

3. The clinical reports on adrenal insufficiency of patients with advanced solid tumors accepting anti-PD-1 antibody, SHR-1210 therapy

Jialin TANG ; Jing HUANG ; Xi WANG ; Xuelian CHEN ; Qun LI ; Hongnan MO ; Dawei WU ; Bo LAN ; Binghe XU

Chinese Journal of Oncology 2019;41(6):466-470

4. Feasibility and toxicity of EC-T dose-dense adjuvant chemotherapy: A real world study in Chinese early-stage breast cancer patients with high recurrence risk

Jiani WANG ; Yuxin MU ; Qing LI ; Ying FAN ; Jiayu WANG ; Fei MA ; Yang LUO ; Peng YUAN ; Shanshan CHEN ; Qiao LI ; Ruigang CAI ; Pin ZHANG ; Binghe XU

Chinese Journal of Oncology 2019;41(5):368-372

5. Clinical observation of thyroid-related adverse events induced by anti-PD-1 antibody SHR-1210 in patients with advanced solid tumor

Ling QI ; Hongnan MO ; Xuelian CHEN ; Xi WANG ; Dawei WU ; Bo LAN ; Qun LI ; Xingyuan WANG ; Jianping XU ; Qing YANG ; Binghe XU ; Jing HUANG

Chinese Journal of Oncology 2018;40(10):772-775

6.A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer.

Binghe XU ; Fuguo TIAN ; Jingrui YU ; Yanqiu SONG ; Jianhua SHI ; Baihong ZHANG ; Yanjun ZHANG ; Zhiping YUAN ; Qiong WU ; Qingyuan ZHANG ; Kejun NAN ; Qiang SUN ; Weilian LI ; Jianbing HU ; Jingwang BI ; Chun MENG ; Hong DAI ; Hongchuan JIANG ; Shun YUE ; Bangwei CAO ; Yuping SUN ; Shu WANG ; Zhongsheng TONG ; Peng SHEN ; Gang WU ; Lili TANG ; Yongchuan DENG ; Liqun JIA ; Kunwei SHEN ; Wu ZHUANG ; Xiaodong XIE ; Youhua WU ; Lin CHEN

Chinese Journal of Oncology 2016;38(1):23-27

7. Genetic variation in DNA polymerase kappa gene is associated with the prognosis after platinum-based chemotherapy in small cell lung cancer patients

Jinna CHEN ; Ting FENG ; Jie YANG ; Hongmin LI ; Peng YUAN ; Fei MA ; Luxi YIN ; Dongxin LIN ; Binghe XU ; Wen TAN

Chinese Journal of Oncology 2019;41(2):112-117

8.Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.

Meiying LI ; Fei MA ; Jiayu WANG ; Qing LI ; Pin ZHANG ; Peng YUAN ; Yang LUO ; Ruigang CAI ; Ying FAN ; Shanshan CHEN ; Qiao LI ; Binghe XU

Chinese Journal of Cancer 2018;37(1):4-4

9.Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.

Binghe XU ; Qingyuan ZHANG ; Xichun HU ; Qing LI ; Tao SUN ; Wei LI ; Quchang OUYANG ; Jingfen WANG ; Zhongsheng TONG ; Min YAN ; Huiping LI ; Xiaohua ZENG ; Changping SHAN ; Xian WANG ; Xi YAN ; Jian ZHANG ; Yue ZHANG ; Jiani WANG ; Liang ZHANG ; Ying LIN ; Jifeng FENG ; Qianjun CHEN ; Jian HUANG ; Lu ZHANG ; Lisong YANG ; Ying TIAN ; Hongyan SHANG

Acta Pharmaceutica Sinica B 2023;13(5):2250-2258

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO